Conditionally replicating adenovirus combined with gene-targeted radiotherapy induces apoptosis via TRAIL death receptors in MDA-MB-231 cells

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 299-305

  Wu, Jia Hui ^a,b   Wang, Hong Fang ^c   Wang, Zhi Cheng ^a   Xu, Kai ^d   Qi, Ya Li ^a,e   Li, Jin Hua ^a   Gong, Shou Liang ^a   Liu, Yang ^a   Liu, Ya ^a  

^a JILIN UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d TIANJIN FIFTH CENTRAL HOSPITAL   (China)

^e BEIHUA UNIVERSITY   (China)

Author keywords

Conditionally replicating adenovirus; Gene radiotherapy; Irradiation; MDA MB 231 cell; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

CASPASE 3; CASPASE 8; CONDITIONALLY REPLICATING ADENOVIRUS; DEATH RECEPTOR 4; MESSENGER RNA;

APOPTOSIS; ARTICLE; CELL KILLING; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; HUMAN; HUMAN CELL; IONIZING RADIATION; IRRADIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RADIOTHERAPY; SIGNAL TRANSDUCTION; VIRUS REPLICATION; X RAY;

ADENOVIRIDAE; APOPTOSIS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HUMANS; PROMOTER REGIONS, GENETIC; RADIATION; RADIOTHERAPY; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND;

ADENOVIRIDAE;

EID: 84878905316     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1488     Document Type: Article

References (28)

1. Weichselbaum RR, Kufe DW, Advani SJ and Roizman B: Molecular targeting of gene therapy and radiotherapy. Acta Oncol 40: 735-738, 2001. (Pubitemid 33081982)
2. Sukhatme VP, Cao XM, Chang LC, et al: A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53: 37-43, 1988.
3. Manente AG, Pinton G, Tavian D, Lopez-Rodas G, Brunelli E and Moro L: Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability. PLoS One 6: e25676, 2011.
4. Du N, Pei XT, Zhou JM, Zhao H, Li XS, Fu Y and Hao YX: Transcriptional control of Flt3 ligand targeted by fluorouracil-induced Egr-1 promoter in hematopoietic damage. J Biomed Sci 16: 85, 2009.
5. Marignol L, Coffey M, Hollywood D and Lawler M: Radiation to control transgene expression in tumors. Cancer Biol Ther 6: 1005-1012, 2007. (Pubitemid 351574948)
6. Weichselbaum RR, Hallahan DE, Beckett MA, Mauceri HJ, Lee H, Sukhatme VP and Kufe DW: Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 54: 4266-4269, 1994. (Pubitemid 24273130)
7. Weichselbaum RR, Halahan DE, Sukhatme VP and Kufe DW: Gene therapy targeted by ionizing radiation. Int J Radiat Oncol Biol Phys 24: 565-567, 1992.
8. Weichselbaum RR: Growth factors alter the therapeutic ratio in radiotherapy. Cancer J Sci Am 1: 28-29, 1995.
9. Weichselbaum RR and Kufe D: Gene therapy of cancer. Lancet 349: 51110-51112, 1997.
10. Yang SW, Chanda D, Cody JJ, Rivera AA, Waehler R, Siegal GP, Douglas JT and Ponnazhagan S: Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer. PLoS One 6: e25131, 2011.
11. Zheng FQ, Xu Y, Yang RJ, Wu B, Tan XH, Qin YD and Zhang QW: Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. Acta Pharmacol Sin 30: 617-627, 2009.
12. Yu W and Fang H: Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 7: 141-148, 2007. (Pubitemid 46348628)
13. Yang SW, Cody JJ, Rivera AA, Waehler R, Wang M, Kimball KJ, Alvarez RA, Siegal GP, Douglas JT and Ponnazhagan S: Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy. Clin Cancer Res 17: 538-549, 2011.
14. Barnes MN, Coolidge CJ, Hemminki A, Alvarez RD and Curiel DT: Conditionally replicative adenoviruses for ovarian cancer therapy. Mol Cancer Ther 1: 435-439, 2002.
15. Gómez-Navarro J and Curiel DT: Conditionally replicative adenoviral vectors for cancer gene therapy. Lancet Oncol 1: 148-158, 2000.
16. Paupoo AA, Zhu ZB, Wang M, Rein DT, Starzinski-Powitz A and Curiel DT: A conditionally replicative adenovirus, CRAd- S-pK7, can target endometriosis with a cell-killing effect. Hum Reprod 25: 2068-2083, 2010.
17. Kimball KJ, Preuss MA, Barnes MN, et al: A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clin Cancer Res 16: 5277-5287, 2010.
18. Wiley SR, Schooley K, Smolak PJ, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995. (Pubitemid 26091143)
19. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999. (Pubitemid 29068521)
20. Gores GJ and Kaufmann SH: Is TRAIL hepatotoxic? Hepatology 34: 3-6, 2001. (Pubitemid 32591476)
21. Wang P, Song JH, Song DK, Zhang J and Hao C: Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Cell Signal 18: 1528-1535, 2006. (Pubitemid 43832088)
22. Mahalingam D, Szegezdi E, Keane M, de Jong S and Samali A: TRAIL receptor signalling and modulation: are we on the right TRAIL? Cancer Treat Rev 35: 280-288, 2009.
23. Kruyt FA: TRAIL and cancer therapy. Cancer Lett 263: 14-25, 2008.
24. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M and Brawley OW: Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 61: 8-30, 2011.
25. Marples B, Greco O, Joiner MC and Scott SD: Radiogenetic therapy: strategies to overcome tumor resistance. Curr Pharm Des 9: 2105-2112, 2003. (Pubitemid 37139087)
26. Ahmed MM: Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors. Curr Cancer Drug Targets 4: 43-52, 2004.
27. Crompton AM and Kim DH: From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development. Curr Cancer Drug Targets 7: 133-139, 2007. (Pubitemid 46348627)
28. Singh TR, Shankar S, Chen X, Asim M and Srivastava RK: Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer Res 63: 5390-5400, 2003. (Pubitemid 37139856)